Attachment 2 - Highlights of Prescribing Information -VYTORIN- Ezetimibe and Simvastatin Tablet Organon LLC
FDA-2026-P-5995-0003Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Attachment 2 - Highlights of Prescribing Information -VYTORIN- Ezetimibe and Simvastatin Tablet Organon LLC
- Posted
- May 28, 2026
- Topics